50% off the $29.99 Customized Fix Kit. Use at checkout:
⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
Exinda Therapeutics
AEO Score: 4/10
Monitoring for AI engine activity
In the Engagemii AEO index
#300,577 of 445,249 in Healthcare for AI visibility
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Exinda Therapeutics just got measured.
4/10 means Exinda Therapeutics is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
About Exinda Therapeutics
Technology IP Pipeline News/Media Contact Continuous Innovation to Enhance Therapeutics Exinda Therapeutics Dedicated to developing pharmaceuticals in oncology and immunomodulation.
Key Topics
Details
AI Visibility Breakdown
1
Structured Data
6
Content Structure
6
Entity Clarity
3
E-E-A-T Signals
5
Technical AEO
4
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Trust Is the Product. AI Is How You Build It at Scale.
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Exinda Therapeutics.
Source & Attribution
Scored by Engagemii on June 30, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/exindarx
Cite this score: Engagemii (2026). "AEO Score for Exinda Therapeutics." Retrieved from https://engagemii.com/aeo/brands/exindarx
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform